1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Influenza Vaccination Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Egg Based
        1.2.3 Cell Culture
        1.2.4 Recombinant
    1.3 Market by Application
        1.3.1 Global Influenza Vaccination Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Research Organizations
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Influenza Vaccination Market Perspective (2017-2028)
    2.2 Influenza Vaccination Growth Trends by Region
        2.2.1 Influenza Vaccination Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Influenza Vaccination Historic Market Size by Region (2017-2022)
        2.2.3 Influenza Vaccination Forecasted Market Size by Region (2023-2028)
    2.3 Influenza Vaccination Market Dynamics
        2.3.1 Influenza Vaccination Industry Trends
        2.3.2 Influenza Vaccination Market Drivers
        2.3.3 Influenza Vaccination Market Challenges
        2.3.4 Influenza Vaccination Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Influenza Vaccination Players by Revenue
        3.1.1 Global Top Influenza Vaccination Players by Revenue (2017-2022)
        3.1.2 Global Influenza Vaccination Revenue Market Share by Players (2017-2022)
    3.2 Global Influenza Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Influenza Vaccination Revenue
    3.4 Global Influenza Vaccination Market Concentration Ratio
        3.4.1 Global Influenza Vaccination Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Influenza Vaccination Revenue in 2021
    3.5 Influenza Vaccination Key Players Head office and Area Served
    3.6 Key Players Influenza Vaccination Product Solution and Service
    3.7 Date of Enter into Influenza Vaccination Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Influenza Vaccination Breakdown Data by Type
    4.1 Global Influenza Vaccination Historic Market Size by Type (2017-2022)
    4.2 Global Influenza Vaccination Forecasted Market Size by Type (2023-2028)
5 Influenza Vaccination Breakdown Data by Application
    5.1 Global Influenza Vaccination Historic Market Size by Application (2017-2022)
    5.2 Global Influenza Vaccination Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Influenza Vaccination Market Size (2017-2028)
    6.2 North America Influenza Vaccination Market Size by Type
        6.2.1 North America Influenza Vaccination Market Size by Type (2017-2022)
        6.2.2 North America Influenza Vaccination Market Size by Type (2023-2028)
        6.2.3 North America Influenza Vaccination Market Share by Type (2017-2028)
    6.3 North America Influenza Vaccination Market Size by Application
        6.3.1 North America Influenza Vaccination Market Size by Application (2017-2022)
        6.3.2 North America Influenza Vaccination Market Size by Application (2023-2028)
        6.3.3 North America Influenza Vaccination Market Share by Application (2017-2028)
    6.4 North America Influenza Vaccination Market Size by Country
        6.4.1 North America Influenza Vaccination Market Size by Country (2017-2022)
        6.4.2 North America Influenza Vaccination Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Influenza Vaccination Market Size (2017-2028)
    7.2 Europe Influenza Vaccination Market Size by Type
        7.2.1 Europe Influenza Vaccination Market Size by Type (2017-2022)
        7.2.2 Europe Influenza Vaccination Market Size by Type (2023-2028)
        7.2.3 Europe Influenza Vaccination Market Share by Type (2017-2028)
    7.3 Europe Influenza Vaccination Market Size by Application
        7.3.1 Europe Influenza Vaccination Market Size by Application (2017-2022)
        7.3.2 Europe Influenza Vaccination Market Size by Application (2023-2028)
        7.3.3 Europe Influenza Vaccination Market Share by Application (2017-2028)
    7.4 Europe Influenza Vaccination Market Size by Country
        7.4.1 Europe Influenza Vaccination Market Size by Country (2017-2022)
        7.4.2 Europe Influenza Vaccination Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Influenza Vaccination Market Size (2017-2028)
    8.2 Asia-Pacific Influenza Vaccination Market Size by Type
        8.2.1 Asia-Pacific Influenza Vaccination Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Influenza Vaccination Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Influenza Vaccination Market Share by Type (2017-2028)
    8.3 Asia-Pacific Influenza Vaccination Market Size by Application
        8.3.1 Asia-Pacific Influenza Vaccination Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Influenza Vaccination Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Influenza Vaccination Market Share by Application (2017-2028)
    8.4 Asia-Pacific Influenza Vaccination Market Size by Region
        8.4.1 Asia-Pacific Influenza Vaccination Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Influenza Vaccination Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Influenza Vaccination Market Size (2017-2028)
    9.2 Latin America Influenza Vaccination Market Size by Type
        9.2.1 Latin America Influenza Vaccination Market Size by Type (2017-2022)
        9.2.2 Latin America Influenza Vaccination Market Size by Type (2023-2028)
        9.2.3 Latin America Influenza Vaccination Market Share by Type (2017-2028)
    9.3 Latin America Influenza Vaccination Market Size by Application
        9.3.1 Latin America Influenza Vaccination Market Size by Application (2017-2022)
        9.3.2 Latin America Influenza Vaccination Market Size by Application (2023-2028)
        9.3.3 Latin America Influenza Vaccination Market Share by Application (2017-2028)
    9.4 Latin America Influenza Vaccination Market Size by Country
        9.4.1 Latin America Influenza Vaccination Market Size by Country (2017-2022)
        9.4.2 Latin America Influenza Vaccination Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Influenza Vaccination Market Size (2017-2028)
    10.2 Middle East & Africa Influenza Vaccination Market Size by Type
        10.2.1 Middle East & Africa Influenza Vaccination Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Influenza Vaccination Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Influenza Vaccination Market Share by Type (2017-2028)
    10.3 Middle East & Africa Influenza Vaccination Market Size by Application
        10.3.1 Middle East & Africa Influenza Vaccination Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Influenza Vaccination Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Influenza Vaccination Market Share by Application (2017-2028)
    10.4 Middle East & Africa Influenza Vaccination Market Size by Country
        10.4.1 Middle East & Africa Influenza Vaccination Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Influenza Vaccination Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Abbott (U.S.)
        11.1.1 Abbott (U.S.) Company Details
        11.1.2 Abbott (U.S.) Business Overview
        11.1.3 Abbott (U.S.) Influenza Vaccination Introduction
        11.1.4 Abbott (U.S.) Revenue in Influenza Vaccination Business (2017-2022)
        11.1.5 Abbott (U.S.) Recent Developments
    11.2 AstraZeneca (Europe)
        11.2.1 AstraZeneca (Europe) Company Details
        11.2.2 AstraZeneca (Europe) Business Overview
        11.2.3 AstraZeneca (Europe) Influenza Vaccination Introduction
        11.2.4 AstraZeneca (Europe) Revenue in Influenza Vaccination Business (2017-2022)
        11.2.5 AstraZeneca (Europe) Recent Developments
    11.3 BioCryst Pharmaceuticals (U.S.)
        11.3.1 BioCryst Pharmaceuticals (U.S.) Company Details
        11.3.2 BioCryst Pharmaceuticals (U.S.) Business Overview
        11.3.3 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Introduction
        11.3.4 BioCryst Pharmaceuticals (U.S.) Revenue in Influenza Vaccination Business (2017-2022)
        11.3.5 BioCryst Pharmaceuticals (U.S.) Recent Developments
    11.4 Novartis (Europe)
        11.4.1 Novartis (Europe) Company Details
        11.4.2 Novartis (Europe) Business Overview
        11.4.3 Novartis (Europe) Influenza Vaccination Introduction
        11.4.4 Novartis (Europe) Revenue in Influenza Vaccination Business (2017-2022)
        11.4.5 Novartis (Europe) Recent Developments
    11.5 DAIICHI SANKYO COMPANY (Asia Pacific)
        11.5.1 DAIICHI SANKYO COMPANY (Asia Pacific) Company Details
        11.5.2 DAIICHI SANKYO COMPANY (Asia Pacific) Business Overview
        11.5.3 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Introduction
        11.5.4 DAIICHI SANKYO COMPANY (Asia Pacific) Revenue in Influenza Vaccination Business (2017-2022)
        11.5.5 DAIICHI SANKYO COMPANY (Asia Pacific) Recent Developments
    11.6 GlaxoSmithKline (Europe)
        11.6.1 GlaxoSmithKline (Europe) Company Details
        11.6.2 GlaxoSmithKline (Europe) Business Overview
        11.6.3 GlaxoSmithKline (Europe) Influenza Vaccination Introduction
        11.6.4 GlaxoSmithKline (Europe) Revenue in Influenza Vaccination Business (2017-2022)
        11.6.5 GlaxoSmithKline (Europe) Recent Developments
    11.7 Hualan Biological Engineering (Asia Pacific)
        11.7.1 Hualan Biological Engineering (Asia Pacific) Company Details
        11.7.2 Hualan Biological Engineering (Asia Pacific) Business Overview
        11.7.3 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Introduction
        11.7.4 Hualan Biological Engineering (Asia Pacific) Revenue in Influenza Vaccination Business (2017-2022)
        11.7.5 Hualan Biological Engineering (Asia Pacific) Recent Developments
    11.8 Mitsubishi Tanabe Pharma (Asia Pacific)
        11.8.1 Mitsubishi Tanabe Pharma (Asia Pacific) Company Details
        11.8.2 Mitsubishi Tanabe Pharma (Asia Pacific) Business Overview
        11.8.3 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Introduction
        11.8.4 Mitsubishi Tanabe Pharma (Asia Pacific) Revenue in Influenza Vaccination Business (2017-2022)
        11.8.5 Mitsubishi Tanabe Pharma (Asia Pacific) Recent Developments
    11.9 F. Hoffmann-La Roche (Europe)
        11.9.1 F. Hoffmann-La Roche (Europe) Company Details
        11.9.2 F. Hoffmann-La Roche (Europe) Business Overview
        11.9.3 F. Hoffmann-La Roche (Europe) Influenza Vaccination Introduction
        11.9.4 F. Hoffmann-La Roche (Europe) Revenue in Influenza Vaccination Business (2017-2022)
        11.9.5 F. Hoffmann-La Roche (Europe) Recent Developments
    11.10 Sanofi (Europe)
        11.10.1 Sanofi (Europe) Company Details
        11.10.2 Sanofi (Europe) Business Overview
        11.10.3 Sanofi (Europe) Influenza Vaccination Introduction
        11.10.4 Sanofi (Europe) Revenue in Influenza Vaccination Business (2017-2022)
        11.10.5 Sanofi (Europe) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Influenza Vaccination Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Egg Based
    Table 3. Key Players of Cell Culture
    Table 4. Key Players of Recombinant
    Table 5. Global Influenza Vaccination Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Influenza Vaccination Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Influenza Vaccination Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Influenza Vaccination Market Share by Region (2017-2022)
    Table 9. Global Influenza Vaccination Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Influenza Vaccination Market Share by Region (2023-2028)
    Table 11. Influenza Vaccination Market Trends
    Table 12. Influenza Vaccination Market Drivers
    Table 13. Influenza Vaccination Market Challenges
    Table 14. Influenza Vaccination Market Restraints
    Table 15. Global Influenza Vaccination Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Influenza Vaccination Revenue Share by Players (2017-2022)
    Table 17. Global Top Influenza Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccination as of 2021)
    Table 18. Ranking of Global Top Influenza Vaccination Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Influenza Vaccination Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Influenza Vaccination Product Solution and Service
    Table 22. Date of Enter into Influenza Vaccination Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Influenza Vaccination Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Influenza Vaccination Revenue Market Share by Type (2017-2022)
    Table 26. Global Influenza Vaccination Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Influenza Vaccination Revenue Market Share by Type (2023-2028)
    Table 28. Global Influenza Vaccination Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Influenza Vaccination Revenue Share by Application (2017-2022)
    Table 30. Global Influenza Vaccination Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Influenza Vaccination Revenue Share by Application (2023-2028)
    Table 32. North America Influenza Vaccination Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Influenza Vaccination Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Influenza Vaccination Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Influenza Vaccination Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Influenza Vaccination Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Influenza Vaccination Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Influenza Vaccination Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Influenza Vaccination Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Influenza Vaccination Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Influenza Vaccination Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Influenza Vaccination Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Influenza Vaccination Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Influenza Vaccination Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Influenza Vaccination Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Influenza Vaccination Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Influenza Vaccination Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Influenza Vaccination Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Influenza Vaccination Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Influenza Vaccination Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Influenza Vaccination Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Influenza Vaccination Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Influenza Vaccination Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Influenza Vaccination Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Influenza Vaccination Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Influenza Vaccination Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Influenza Vaccination Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Influenza Vaccination Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Influenza Vaccination Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Influenza Vaccination Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Influenza Vaccination Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Abbott (U.S.) Company Details
    Table 63. Abbott (U.S.) Business Overview
    Table 64. Abbott (U.S.) Influenza Vaccination Product
    Table 65. Abbott (U.S.) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 66. Abbott (U.S.) Recent Developments
    Table 67. AstraZeneca (Europe) Company Details
    Table 68. AstraZeneca (Europe) Business Overview
    Table 69. AstraZeneca (Europe) Influenza Vaccination Product
    Table 70. AstraZeneca (Europe) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 71. AstraZeneca (Europe) Recent Developments
    Table 72. BioCryst Pharmaceuticals (U.S.) Company Details
    Table 73. BioCryst Pharmaceuticals (U.S.) Business Overview
    Table 74. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product
    Table 75. BioCryst Pharmaceuticals (U.S.) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 76. BioCryst Pharmaceuticals (U.S.) Recent Developments
    Table 77. Novartis (Europe) Company Details
    Table 78. Novartis (Europe) Business Overview
    Table 79. Novartis (Europe) Influenza Vaccination Product
    Table 80. Novartis (Europe) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 81. Novartis (Europe) Recent Developments
    Table 82. DAIICHI SANKYO COMPANY (Asia Pacific) Company Details
    Table 83. DAIICHI SANKYO COMPANY (Asia Pacific) Business Overview
    Table 84. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product
    Table 85. DAIICHI SANKYO COMPANY (Asia Pacific) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 86. DAIICHI SANKYO COMPANY (Asia Pacific) Recent Developments
    Table 87. GlaxoSmithKline (Europe) Company Details
    Table 88. GlaxoSmithKline (Europe) Business Overview
    Table 89. GlaxoSmithKline (Europe) Influenza Vaccination Product
    Table 90. GlaxoSmithKline (Europe) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 91. GlaxoSmithKline (Europe) Recent Developments
    Table 92. Hualan Biological Engineering (Asia Pacific) Company Details
    Table 93. Hualan Biological Engineering (Asia Pacific) Business Overview
    Table 94. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product
    Table 95. Hualan Biological Engineering (Asia Pacific) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 96. Hualan Biological Engineering (Asia Pacific) Recent Developments
    Table 97. Mitsubishi Tanabe Pharma (Asia Pacific) Company Details
    Table 98. Mitsubishi Tanabe Pharma (Asia Pacific) Business Overview
    Table 99. Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product
    Table 100. Mitsubishi Tanabe Pharma (Asia Pacific) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 101. Mitsubishi Tanabe Pharma (Asia Pacific) Recent Developments
    Table 102. F. Hoffmann-La Roche (Europe) Company Details
    Table 103. F. Hoffmann-La Roche (Europe) Business Overview
    Table 104. F. Hoffmann-La Roche (Europe) Influenza Vaccination Product
    Table 105. F. Hoffmann-La Roche (Europe) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 106. F. Hoffmann-La Roche (Europe) Recent Developments
    Table 107. Sanofi (Europe) Company Details
    Table 108. Sanofi (Europe) Business Overview
    Table 109. Sanofi (Europe) Influenza Vaccination Product
    Table 110. Sanofi (Europe) Revenue in Influenza Vaccination Business (2017-2022) & (US$ Million)
    Table 111. Sanofi (Europe) Recent Developments
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Influenza Vaccination Market Share by Type: 2021 VS 2028
    Figure 2. Egg Based Features
    Figure 3. Cell Culture Features
    Figure 4. Recombinant Features
    Figure 5. Global Influenza Vaccination Market Share by Application: 2021 VS 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Research Organizations Case Studies
    Figure 8. Influenza Vaccination Report Years Considered
    Figure 9. Global Influenza Vaccination Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Influenza Vaccination Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Influenza Vaccination Market Share by Region: 2021 VS 2028
    Figure 12. Global Influenza Vaccination Market Share by Players in 2021
    Figure 13. Global Top Influenza Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccination as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Influenza Vaccination Revenue in 2021
    Figure 15. North America Influenza Vaccination Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Influenza Vaccination Market Size Market Share by Type (2017-2028)
    Figure 17. North America Influenza Vaccination Market Size Market Share by Application (2017-2028)
    Figure 18. North America Influenza Vaccination Market Size Share by Country (2017-2028)
    Figure 19. United States Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Influenza Vaccination Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Influenza Vaccination Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Influenza Vaccination Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Influenza Vaccination Market Size Share by Country (2017-2028)
    Figure 25. Germany Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Influenza Vaccination Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Influenza Vaccination Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Influenza Vaccination Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Influenza Vaccination Market Size Share by Region (2017-2028)
    Figure 35. China Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Influenza Vaccination Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Influenza Vaccination Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Influenza Vaccination Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Influenza Vaccination Market Size Share by Country (2017-2028)
    Figure 45. Mexico Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Influenza Vaccination Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Influenza Vaccination Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Influenza Vaccination Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Influenza Vaccination Market Size Share by Country (2017-2028)
    Figure 51. Turkey Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Influenza Vaccination Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Abbott (U.S.) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 55. AstraZeneca (Europe) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 56. BioCryst Pharmaceuticals (U.S.) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 57. Novartis (Europe) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 58. DAIICHI SANKYO COMPANY (Asia Pacific) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 59. GlaxoSmithKline (Europe) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 60. Hualan Biological Engineering (Asia Pacific) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 61. Mitsubishi Tanabe Pharma (Asia Pacific) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 62. F. Hoffmann-La Roche (Europe) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 63. Sanofi (Europe) Revenue Growth Rate in Influenza Vaccination Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed